Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NUDT1 | P36639 | 2/20 | 0.68 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.63 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.63 |
| ▸ | PI4KA | P42356 | 8/20 | 0.54 |
| ▸ | PI4K2B | Q8TCG2 | 8/20 | 0.54 |
| ▸ | PI4K2A | Q9BTU6 | 8/20 | 0.54 |
| ▸ | PI4KB | Q9UBF8 | 8/20 | 0.54 |
| ▸ | LMNA | P02545 | 3/20 | 0.49 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | DRD3 | P35462 | 1/20 | 0.48 |
| ▸ | XDH | P47989 | 1/20 | 0.48 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.48 |
| ▸ | AKT2 | P31751 | 1/20 | 0.47 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.46 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | HSP90AB1 | P08238 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.46 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1059581 | 1.00 | NUDT1 (0.68) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL42314 | 0.81 | ADORA2A (0.66) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL887194 | 0.79 | ADORA2A (0.58) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL8566 | 0.78 | ADORA2A (1.00) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL42335 | 0.78 | ADORA2A (0.61) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL31096978 | 0.78 | ADORA2A (0.61) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL842440 | 0.78 | ADORA2A (0.61) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL30962317 | 0.78 | ADORA2A (0.61) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL842891 | 0.78 | ADORA2A (0.61) | NUDT1ADORA2AADORA1PI4KAPI4K2B | |
| SCHEMBL843169 | 0.78 | ADORA2A (0.61) | NUDT1ADORA2AADORA1PI4KAPI4K2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128799-A1 | DOUBLE-STRANDED RNA-EDITING OLIGONUCLEOTIDES AND USES THEREOF | KORRO BIO, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| CN-119431453-A | Phosphorus (V) based reagent, method for the production thereof, and use thereof for producing stereoregular organic phosphorus (V) compounds | 百时美施贵宝公司 | 2025-02-14 | — | — | CN | disclosed |
| EP-4504939-A2 | METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | Takeda Pharmaceuticals U.S.A., Inc. (US) | 2025-02-12 | — | — | EP | disclosed |
| WO-2024182578-A1 | OLIGONUCLEOTIDES FOR RNA EDITING | KORRO BIO, INC. (US) | 2024-09-06 | — | — | WO | disclosed |
| EP-4419683-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING NRF2-KEAP1 PROTEIN INTERACTION BY ADAR MEDIATED RNA EDITING | Korro Bio, Inc. (US) | 2024-08-28 | — | — | EP | disclosed |
| EP-4408532-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF PCDH19 RELATED DISORDERS | The Florey Institute of Neuroscience and Mental Health (AU) | 2024-08-07 | — | — | EP | disclosed |
| WO-2022256283-A9 | METHODS FOR RESTORING PROTEIN FUNCTION USING ADAR | KORRO BIO, INC. (US) | 2023-12-28 | — | — | WO | disclosed |
| WO-2023193004-A2 | METHODS FOR THE TREATMENT OF NEURODEGENERATIVE DISORDERS | TRIPLET THERAPEUTICS, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| WO-2023069603-A1 | METHODS AND COMPOSITIONS FOR DISRUPTING NRF2-KEAP1 PROTEIN INTERACTION BY ADAR MEDIATED RNA EDITING | KORRO BIO, INC. (US) | 2023-04-27 | — | — | WO | disclosed |
| EP-4157359-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF SERPINA1 | Korro Bio, Inc. (US) | 2023-04-05 | — | — | EP | disclosed |
| EP-4150078-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF ARGININOSUCCINATE LYASE (ASL) | Korro Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4150077-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF TRANSMEMBRANE CHANNEL-LIKE PROTEIN 1 (TMC1) | Korro Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4150076-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF METHYL-CPG BINDING PROTEIN 2 (MECP2) | Korro Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4150088-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF ARGININOSUCCINATE SYNTHETASE (ASS1) | Korro Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4150089-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF RETINOSCHISIN 1 (RS1) | Korro Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4150086-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF LEUCINE RICH REPEAT KINASE 2 (LRRK2) | Korro Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| EP-4150090-A1 | METHODS AND COMPOSITIONS FOR THE ADAR-MEDIATED EDITING OF OTOFERLIN (OTOF) | Korro Bio, Inc. (US) | 2023-03-22 | — | — | EP | disclosed |
| WO-2023278407-A1 | METHODS AND COMPOSITIONS FOR ADAR-MEDIATED EDITING | KORRO BIO, INC. (US) | 2023-01-05 | — | — | WO | disclosed |
| WO-2023278410-A1 | METHODS AND COMPOSITIONS FOR ADAR-MEDIATED EDITING | KORRO BIO, INC. (US) | 2023-01-05 | — | — | WO | disclosed |
| WO-2022256283-A2 | METHODS FOR RESTORING PROTEIN FUNCTION USING ADAR | KORRO BIO, INC. (US) | 2022-12-08 | — | — | WO | disclosed |